By adopting the Veeva Digital Trials Platform, LEO Pharma plans to significantly improve the clinical trial process while maintaining the highest standards of data accuracy, regulatory compliance, and patient safety:
Reduction
in clinical trial costs
Reduction
in clinical trial time
Higher
clinical data accuracy
Increased
patient diversity and improved patient experience
"Together with Veeva, we want to develop a platform that shapes and improves the experience of patients that participate in clinical studies."
Jörg Möller
Head of Global Research and Development at Leo Pharma
Making clinical trials easier and faster for patients, sites, and sponsors.
Enabling scalable, digital trials that are patient-centric and paperless.
Bringing innovative treatments to patients faster while also supporting a more sustainable business.
Resources
Survey Report
Industry Shifts Toward Connected, Digital Trials to Accelerate Research
Article
Data First: Building a Foundation for Digital and Decentralized Clinical Trials
Article
Clinical Trials Prepare for a Digital, Connected Future